REV 25 mg (Revlimid 25 mg)
Generic Name: lenalidomide
Pill imprint REV 25 mg has been identified as Revlimid 25 mg.
Revlimid is used in the treatment of multiple myeloma; lymphoma; myelodysplastic diseases; mantle cell lymphoma; anemia and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- lenalidomide
- Imprint:
- REV 25 mg
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antineoplastics
Other immunosuppressants - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Celgene Corporation
- National Drug Code (NDC):
- 59572-0425
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
More about Revlimid (lenalidomide)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
